An ointment for plaque psoriasis in children and teens
Part of Skin clinical trials.
This study tests whether a new ointment (called RSS0393) is safe and works well for young people with plaque psoriasis. It may help reduce the thick, scaly patches of skin caused by this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 6 and 17 years old.
- You have had plaque psoriasis (the most common type) for at least 3 months.
- You and your parent or guardian agree to join and sign a consent form.
- You do not have other types of psoriasis or skin conditions that could affect the study.
- You have not used certain psoriasis creams recently, pills or light therapy within the past month, or biologic shots within the past few months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an ointment called RSS0393 to see if it safely reduces the redness, thickness, and scaling of plaque psoriasis. It may help if you have mild-to-moderate psoriasis that is not well controlled with current treatments.
This study tests a new medication called SHR-1314 for teenagers aged 6 to under 18 with moderate to severe plaque psoriasis. It aims to see if the treatment is safe and effective in reducing psoriasis symptoms.
This study tests a new medicine called IBI112 for teens aged 12–18 with moderate to severe plaque psoriasis. It aims to see if the medicine is safe and can help clear skin better than placebo.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
This trial tests an ointment (RSS0393) for plaque psoriasis. It aims to see if the ointment reduces the size and severity of psoriasis patches and is safe to use.
This study tests a new medicine (HS-20137) for moderate-to-severe plaque psoriasis, a condition causing thick, scaly patches on the skin. It aims to see if this medicine can safely reduce the severity of psoriasis and improve quality of life.
Hear when a new Plaque Psoriasis in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.